Article Text

Download PDFPDF

In Memoriam: Dr Michel Roy
  1. Marie Plante1 and
  2. Pedro T Ramirez2
  1. 1 Obstetrics, Gynecology and Reproduction, CHU de Quebec-Universite Laval, Quebec, Quebec, Canada
  2. 2 MD Anderson Cancer Center, Houston, Texas, USA
  1. Correspondence to Dr Pedro T Ramirez, MD Anderson Cancer Center, Houston, Texas, USA; peramire{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

It is with deep sadness that we inform the international gynecologic oncology community that our friend and colleague Dr Michel Roy passed away on July 7, 2021. He had a remarkably successful career in gynecologic oncology at L’Hôtel-Dieu de Quebec for 40 years (1974–2014) and for which he received the Professor Emeritus honor from Laval University in recognition of all his achievements.

He was one of the founding members of the Society of Gynecologic Oncology of Canada (GOC), a founding member of the Society of Colposcopists of Canada (SCC), and was President of the ISSVD (1993). Besides being one of the leading colposcopists in Canada in the 1970s and 1980s, he pioneered numerous surgical techniques such as laparoscopic lymphadenectomy, sentinel node mapping, vaginal radical hysterectomy (Schauta operation) and, most importantly, he was the first to perform vaginal radical trachelectomy in North America. He was the first to report the birth of a child following this procedure in North America.

Dr Roy was an inspiration to many in the field of gynecologic oncology and his contributions will have a lasting impact on many women diagnosed with cancer. He was a passionate and inquisitive learner and an advocate of training and exploration for many young trainees and faculty. He was generous of his time, his intellect, and his devotion for teaching transformed the lives of many.

His contribution and influence in the field of gynecologic oncology in Quebec, Canada and internationally was immense. He will be deeply missed. To honor his memory, the Division of Gynecologic Oncology has created ‘Le Fonds Michel Roy pour l’Excellence en Gynécologie Oncologique’.

Ethics statements

Patient consent for publication


  • Twitter @pedroramirezMD

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.